Silo Pharma, Inc. (SILO) shareholders
Close on Nov 17, 2026Market cap $2.72MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Tony Moore Joint filing with Anson Funds Management LP (7.20%), Anson Management GP LLC (7.20%) and 3 more | 952,381 | 7.20% | 13G (passive) | Sep 30, 2025 |
| Intracoastal Capital LLC Joint filing with Mitchell P. Kopin (9.99%), Daniel B. Asher (9.99%) | 838,081 | 9.99% | 13G (passive) amendment | Jun 30, 2025 |
| Renaissance Technologies Holdings Corporation Joint filing with Renaissance Technologies LLC (5.06%) | 227,006 | 5.06% | 13G (passive) | Sep 4, 2024 |
| Mitchell P. Kopin Joint filing with Daniel B. Asher (9.99%), Intracoastal Capital LLC (9.99%) | 176,165 | 9.99% | 13G (passive) amendment | Sep 30, 2026 |
| Daniel B. Asher Joint filing with Mitchell P. Kopin (9.99%), Intracoastal Capital LLC (9.99%) | 125,261 | 9.99% | 13G (passive) amendment | Jun 30, 2026 |
| AdvisorShares Trust | 75,582 | 6.69% | 13G (passive) | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of SILO | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| AdvisorShares Investments LLC | 75,582 | 4.76% | $469.36K | New | 0.06% |
| FNY Investment Advisers, LLC | 37,507 | 2.36% | $232.00K | New | 0.08% |
| Citadel Advisors LLC | 16,800 | 1.06% | $104.33K | New | 0.00% |
| Vanguard Capital Management LLC | 11,956 | 0.75% | $74.25K | New | 0.00% |
| Vanguard Fiduciary Trust Co | 874 | 0.06% | $5.43K | New | 0.00% |
| Tower Research Capital LLC (TRC) | 181 | 0.01% | $1.12K | New | 0.00% |
| Harbour Investments, Inc. | 14 | 0.00% | $87 | New | 0.00% |
| Citigroup Inc | 1 | 0.00% | $6 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 8 | 0M | 9.0% | 8 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
5 funds held SILO in Q1 2026, 88% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of SILO | Value | % of fund | As of |
|---|---|---|---|---|---|
| AdvisorShares Psychedelics ETF | 75,582 | 4.76% | $469.36K | 1.06% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 11,956 | 0.75% | $74.25K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Eric Weisblum | Chief Executive Officer, Director | 214,432 | 13.50% | Dec 16, 2025 |
| Daniel E. Ryweck | Chief Financial Officer | 5,000 | 0.31% | May 27, 2025 |
| Wayne Linsley | Director | – | – | May 27, 2025 |
| Kevin Munoz | Director | – | – | May 27, 2025 |
| Jeff Pavell | Director | – | – | May 27, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Eric Weisblum Chief Executive Officer, Director | Dec 15, 2025 | Buy | +2,500 | $0.41 | $1.03K | 214,432 |
| Eric Weisblum Chief Executive Officer, Director | Dec 15, 2025 | Buy | +2,500 | $0.42 | $1.05K | 216,932 |
| Eric Weisblum Chief Executive Officer, Director | Nov 21, 2025 | Buy | +1,000 | $0.37 | $370 | 211,932 |
| Eric Weisblum Chief Executive Officer, Director | Nov 20, 2025 | Buy | +1,000 | $0.37 | $370 | 210,932 |
| Eric Weisblum Chief Executive Officer, Director | Nov 19, 2025 | Buy | +4,500 | $0.41 | $1.85K | 209,932 |
| Eric Weisblum Chief Executive Officer, Director | Nov 18, 2025 | Buy | +7,500 | $0.40 | $3.00K | 205,432 |
| Eric Weisblum Chief Executive Officer, Director | May 27, 2025 | Buy | +10,000 | $0.43 | $4.30K | 197,932 |
| Eric Weisblum CEO and President, Director | Dec 13, 2024 | Buy | +2,500 | $0.84 | $2.10K | 187,932 |
| Eric Weisblum CEO and President, Director | Nov 22, 2024 | Buy | +2,500 | $0.90 | $2.25K | 185,432 |
| Eric Weisblum CEO and President, Director | Nov 20, 2024 | Buy | +2,500 | $0.95 | $2.38K | 182,932 |
| Eric Weisblum CEO and President, Director | Jun 12, 2024 | Buy | +4,438 | $1.11 | $4.93K | 180,432 |
| Eric Weisblum CEO and President, Director | Jun 11, 2024 | Buy | +562 | $1.08 | $607 | 175,994 |
| Eric Weisblum CEO and President, Director | Apr 5, 2024 | Buy | +400 | $2.03 | $812 | 175,432 |
| Eric Weisblum CEO and President, Director | Apr 4, 2024 | Buy | +600 | $1.96 | $1.18K | 175,032 |
| Eric Weisblum CEO and President, Director | Apr 1, 2024 | Buy | +1,100 | $1.91 | $2.10K | 174,432 |
| Eric Weisblum CEO and President, Director | Mar 28, 2024 | Buy | +3,408 | $1.94 | $6.61K | 173,332 |
| Eric Weisblum CEO and President, Director | Dec 20, 2023 | Buy | +200 | $1.61 | $322 | 169,924 |
| Eric Weisblum CEO and President, Director | Dec 19, 2023 | Buy | +500 | $1.63 | $815 | 169,724 |
| Eric Weisblum CEO and President, Director | Dec 15, 2023 | Buy | +900 | $1.52 | $1.37K | 169,224 |
| Eric Weisblum CEO and President, Director | Dec 14, 2023 | Buy | +200 | $1.50 | $300 | 168,324 |
| Eric Weisblum CEO and President, Director | Dec 7, 2023 | Buy | +324 | $1.36 | $441 | 168,124 |
| Eric Weisblum CEO and President, Director | Dec 6, 2023 | Buy | +76 | $1.34 | $102 | 167,800 |
| Eric Weisblum CEO and President, Director | Dec 5, 2023 | Buy | +600 | $1.39 | $834 | 167,724 |
| Eric Weisblum CEO and President, Director | Nov 30, 2023 | Buy | +1,000 | $1.53 | $1.53K | 167,124 |
| Eric Weisblum CEO and President, Director | Nov 29, 2023 | Buy | +1,000 | $1.57 | $1.57K | 166,124 |
| Eric Weisblum CEO and President, Director | Nov 27, 2023 | Buy | +250 | $1.78 | $445 | 165,124 |
| Eric Weisblum CEO and President, Director | Nov 22, 2023 | Buy | +400 | $1.68 | $672 | 164,874 |
| Eric Weisblum CEO and President, Director | Nov 21, 2023 | Buy | +300 | $1.56 | $468 | 164,474 |
| Eric Weisblum CEO and President, Director | Nov 20, 2023 | Buy | +4,050 | $1.60 | $6.48K | 164,174 |
| Eric Weisblum CEO and President, Director | Nov 17, 2023 | Buy | +1,800 | $1.54 | $2.77K | 160,124 |
| Eric Weisblum CEO and President, Director | Nov 16, 2023 | Buy | +1,100 | $1.33 | $1.46K | 158,324 |
| Daniel E. Ryweck Chief Financial Officer | May 26, 2023 | Buy | +1,000 | $2.13 | $2.13K | 5,000 |
| Eric Weisblum CEO and President, Director | May 18, 2023 | Buy | +500 | $2.11 | $1.06K | 157,724 |
| Eric Weisblum CEO and President, Director | May 17, 2023 | Buy | +2,500 | $2.06 | $5.15K | 157,224 |
| Eric Weisblum CEO and President, Director | Dec 20, 2022 | Buy | +130 | $2.72 | $354 | 154,854 |
| Eric Weisblum CEO and President, Director | Dec 19, 2022 | Buy | +200 | $2.68 | $536 | 154,724 |
| Eric Weisblum CEO and President, Director | Dec 14, 2022 | Buy | +263 | $3.17 | $834 | 154,524 |
| Eric Weisblum CEO and President, Director | Dec 13, 2022 | Buy | +487 | $3.07 | $1.50K | 154,261 |
| Eric Weisblum CEO, CFO and President, Director | Jun 17, 2022 | Buy | +13,080 | $0.11 | $1.44K | 7,724,643 |
| Eric Weisblum Chief Executive Officer, Director | Dec 13, 2021 | Buy | +17,500 | $0.14 | $2.45K | 7,711,563 |
| Eric Weisblum Chief Executive Officer, Director | Dec 10, 2021 | Buy | +5,000 | $0.16 | $800 | 7,694,063 |
| Eric Weisblum CEO, CFO and President, Director | Apr 28, 2020 | Award | +7,630,949 | – | – | 7,689,063 |
| Eric Weisblum CHIEF EXECUTIVE OFFICER, Director | Apr 17, 2020 | Award | +7,630,949 | – | – | 7,988,663 |
| Eric Weisblum CEO, CFO and President, Director | Oct 22, 2019 | Buy | +200 | $0.45 | $90 | 58,114 |
| Eric Weisblum CEO, CFO and President, Director | Oct 15, 2019 | Buy | +200 | $0.38 | $76 | 57,914 |
| Eric Weisblum CEO, CFO and President, Director | Jun 17, 2019 | Buy | +57,714 | – | – | 57,714 |
| Eric Weisblum Pres, Chief Compliance Officer, Director | Sep 4, 2014 | Gift | −3,584,160 | $1.00 | $3.58M | 0 |
| Van Eps Parker Director | Jul 30, 2014 | Award | +37,500 | – | – | 37,500 |
| Eric Weisblum President and CCO, Director | Jun 20, 2013 | Award | +3,584,160 | – | – | 3,584,160 |
| Richard Brand Chairman and CEO, Director | Jun 20, 2013 | Award | +2,042,080 | – | – | 2,042,080 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Silo Pharma's stock actually held short. Settlement fails (shares not delivered on time) peaked at 15,448 shares on Sep 21, 2026 over the last 90 days.
See a number that looks wrong?